RBMX and neoplasm: Through animal models combined with single-cell transcriptome sequencing analysis, it was discovered that knockout of RBMX significantly enhanced the infiltration of immune cells in the tumor microenvironment, suggesting that intervening in the expression of RBMX may help make tumors more likely to respond to immunotherapy.